Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
19/11/201514h00Business WireTeva Reports Positive Top-Line Results from Phase III Trials Evaluating Fluticasone Propionate/Salmeterol & Fluticasone Propi...NYSE:TEVATeva Pharmaceutical Industries Ltd
19/11/201509h02Dow Jones NewsShares Of Deal Targets Reflect Regulatory FearNYSE:TEVATeva Pharmaceutical Industries Ltd
18/11/201522h51Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
17/11/201514h04Business WireTeva to Present at the Jefferies Autumn 2015 Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
16/11/201513h41The Motley FoolBetter Dividend Stock: Gilead Sciences Inc. vs. Teva Pharmaceutical IndustriesNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201513h20The Motley FoolGeneric Drugmakers Block Suitors, but Is That Good or Bad News?NYSE:TEVATeva Pharmaceutical Industries Ltd
13/11/201516h08Dow Jones NewsMylan Loses Hostile Bid for Perrigo--2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
13/11/201515h40Dow Jones NewsMylan Loses Hostile Bid for PerrigoNYSE:TEVATeva Pharmaceutical Industries Ltd
13/11/201515h34Dow Jones NewsMylan Loses Hostile Bid for Perrigo--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
13/11/201506h15Dow Jones NewsMylan Set to Lose in $26 Billion Hostile Takeover Battle for Perrigo -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
13/11/201505h20Dow Jones NewsMylan Set to Lose in $26 Billion Hostile Takeover Battle for PerrigoNYSE:TEVATeva Pharmaceutical Industries Ltd
12/11/201500h28The Motley FoolWhy Insys Therapeutics Shares Dropped TodayNYSE:TEVATeva Pharmaceutical Industries Ltd
09/11/201514h00Business WireTeva Announces Breakthrough Therapy Designation for SD-809 Granted by FDA for the Treatment of Tardive DyskinesiaNYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201515h20Dow Jones NewsAllergan Sales Soar, Topping ExpectationsNYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201514h00Business WireTeva to Present New Respiratory Data at the 2015 Annual Scientific Meeting of the American College of Allergy, Asthma & Immun...NYSE:TEVATeva Pharmaceutical Industries Ltd
31/10/201521h41The Motley FoolTeva Pharmaceutical Industries Ltd. Sees Stronger 2015 After Q3 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
31/10/201514h21The Motley FoolGeneric Copaxone Isn't Derailing Teva Pharmaceuticals...YetNYSE:TEVATeva Pharmaceutical Industries Ltd
29/10/201515h20Dow Jones NewsAllergan Confirms Pfizer TalksNYSE:TEVATeva Pharmaceutical Industries Ltd
29/10/201514h10Dow Jones NewsTeva Boosts Outlook as Results Top EstimatesNYSE:TEVATeva Pharmaceutical Industries Ltd
29/10/201512h00Business WireTeva Reports Third Quarter 2015 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
24/10/201515h12The Motley FoolSpecialty Drug Classes That Are Costing Consumers an Arm and a LegNYSE:TEVATeva Pharmaceutical Industries Ltd
23/10/201519h39PR Newswire (US)New Data Presented at European Society of Gynecology Congress Show Most Women Would Prefer to Have Less Frequent PeriodsNYSE:TEVATeva Pharmaceutical Industries Ltd
23/10/201503h45The Motley FoolBiogen's Beat, Raise, and YawnNYSE:TEVATeva Pharmaceutical Industries Ltd
15/10/201515h24Business WireTeva to Host Third Quarter 2015 Financial Results Conference Call and Webcast on October 29, 2015NYSE:TEVATeva Pharmaceutical Industries Ltd
12/10/201514h30Business WireTeva Announces Exclusive Launch of Generic Avodart® Capsules in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
08/10/201514h00Business WireTeva Announces Approval of Three-Times-A-Week COPAXONE® 40 mg/mL in Russia for the Treatment of Relapsing-Remitting Multiple...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/10/201502h58Dow Jones NewsCorrection to Alkermes Story From Oct. 5NYSE:TEVATeva Pharmaceutical Industries Ltd
06/10/201514h00Business WireTeva Reinforces Focus on Advancing Multiple Sclerosis Treatment at 31st ECTRIMS CongressNYSE:TEVATeva Pharmaceutical Industries Ltd
06/10/201503h06Dow Jones NewsFDA Approves Alkermes' Schizophrenia Treatment AristadaNYSE:TEVATeva Pharmaceutical Industries Ltd
01/10/201515h50Dow Jones NewsTeva to Acquire Mexico Drug Maker Rimsa for $2.3 BillionNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA